Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how the growing global aging population is inciting the health-tech industry to create innovative solutions to address growing concerns affecting this demographic, whether through hearing aids, oral aids or CBD oil.
According to Acumen Research and Consulting, the global Ear-Nose-Throat (ENT) devices market is forecast to grow at a stable CAGR around 8% during the period 2018 to 2026. In the report named “Ear-Nose-Throat (ENT) Devices Market” – Global Industry Analysis, Growth, Share, Size, Trends and Forecast, 2018-2026”, rising incorporation of advanced technology, growing awareness about various health-related issues, ever-increasing healthcare costs, favorable regulatory backdrop for ENT devices, increasing geriatric population, technological advancements, user-friendly ENT devices changing lifestyle patterns and ease of availability of various ear-nose-throat devices are some of the key factors that are fuelling the ear-nose-throat devices market growth across the globe.
Read this in full at
This was reaffirmed in the The State of Hearing Report conducted for Cochlear Limited (ASX: COH), which revealed that many people know that adults with hearing loss are facing social isolation, declining self-esteem and losing the ability to communicate as their families feel the strain and that a solution could start by people simply changing how they think about hearing loss and recognizing it can often be preventable and treatable.
InnerScope Hearing Technologies Inc. (OTCQB: INND), a manufacturer and Direct-to-Consumer distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifier Products, Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CBD Oil, recently announced that it has entered into an Agreement with AsSeenOnTV.pro to produce Direct Response TV and Brand Response TV commercials promoting its Self-Fitting Hearing Aids (“NEXUS”), Dietary Hearing Supplements “Nutrition for the Ears” and CBD Oil. The Hearing Product Commercials will feature Kevin Harrington, the pioneer of the ‘As Seen On TV’ empire and an original “Shark” from the Emmy award-winning TV reality show, Shark Tank. Kevin Harrington is also the Co-Executive Producer and the mastermind behind AsSeenOnTV.pro DRTV/BRTV campaigns.
Mr. Harrington commented “Having known and worked with the founders of InnerScope in the past, I know their passion and expertise in helping the tens of millions of people that have hearing related problems. With 48 million people in the US alone that have reported having hearing issues, InnerScope’s Hearing Aids and Hearing Health Products have mass-market appeal. This is one of the reasons my team thinks InnerScope is a good fit to create an Omni-Channel TV/Video Media Campaign to target those tens of millions of potential customers.”
Generex Biotechnology Corporation (OTC: GNBT), who, through its subsidiaries engages in the administration of formulations of large molecule drugs to the oral cavity, recently announced that the company’s subsidiary Olaregen Therapeutix participated as a sponsor of the prestigious Diabetic Limb Salvage Conference in Washington, DC as part of its continued commitment to Wound Care Education. The Conference was attended by 600 influential experts and healthcare providers involved in the research and management of wounds, with specific emphasis on diabetic foot ulcers (DFUs). Olaregen hosted an exhibit to present information on its now commercial wound care product, Excellagen®, formulated fibrillar collagen (2.6%) wound conforming matrix, indicated for the management of several wound types, significant among them, DFUs.
Organovo Holdings, Inc. (NASDAQ: ONVO), a biotechnology company pioneering the development of 3D bio-printed tissues aimed at treating a range of serious adult and pediatric liver diseases, announced that Chief Medical Officer, Dr. Steven G. Hughes is scheduled to speak at the inaugural Cell & Gene Meeting on the Mediterranean to be held April 23-25 in Barcelona, Spain.
This event, modeled after The Alliance for Regenerative Medicine’s (“ARM”) highly successful Cell & Gene Meeting on the Mesa held annually in La Jolla, California, is expected to attract more than 250 attendees, including senior executives from leading cell therapy, gene therapy, and tissue engineering companies worldwide, large pharma and biotech representatives, institutional investors, academic research institutions, patient foundations, disease philanthropies and members of the life science media community.
This “new age trend” of focusing on awareness and access with regards to healthcare technology for this expanding, aging population is proving to be a valued component for the industry. It’s now “good business” to care for our elders.
For investors following medical technology and healthcare stocks, Investor Ideas has created a directory of biotech and medical technology stocks
About Investorideas.com – News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third-party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts, and videos talking about cannabis, crypto, technology including AI and IoT, mining, sports biotech, water, renewable energy and more. Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Follow us on Social Media
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Get free news alerts
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews, and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this news article featuring InnerScope Hearing Technologies is a paid for service on Investorideas.com(third party)
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Get more Biotech Investor Ideas – news, articles and stock directories